GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Axsome Therapeutics Inc (STU:19X) » Definitions » Price-to-Tangible-Book

Axsome Therapeutics (STU:19X) Price-to-Tangible-Book : 142.56 (As of Dec. 14, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Axsome Therapeutics Price-to-Tangible-Book?

As of today (2024-12-14), Axsome Therapeutics's share price is €85.82. Axsome Therapeutics's Tangible Book per Share of Sep. 2024 for the quarter that ended in Sep. 2024 was €0.60. Hence, Axsome Therapeutics's Price to Tangible Book Ratio of today is 142.56.

The historical rank and industry rank for Axsome Therapeutics's Price-to-Tangible-Book or its related term are showing as below:

STU:19X' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 3.14   Med: 22.09   Max: 141.27
Current: 134.09

During the past 11 years, Axsome Therapeutics's highest Price to Tangible Book Ratio was 141.27. The lowest was 3.14. And the median was 22.09.

STU:19X's Price-to-Tangible-Book is ranked worse than
99.17% of 1205 companies
in the Biotechnology industry
Industry Median: 2.81 vs STU:19X: 134.09

A closely related ratio is called PB Ratio. As of today, Axsome Therapeutics's share price is €85.82. Axsome Therapeutics's Book Value per Sharefor the quarter that ended in Sep. 2024 was €1.73. Hence, Axsome Therapeutics's P/B Ratio of today is 49.66.


Axsome Therapeutics Price-to-Tangible-Book Historical Data

The historical data trend for Axsome Therapeutics's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Axsome Therapeutics Price-to-Tangible-Book Chart

Axsome Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.24 26.44 84.86 82.21 29.13

Axsome Therapeutics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.03 29.13 48.19 93.68 133.42

Competitive Comparison of Axsome Therapeutics's Price-to-Tangible-Book

For the Biotechnology subindustry, Axsome Therapeutics's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Axsome Therapeutics's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Axsome Therapeutics's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Axsome Therapeutics's Price-to-Tangible-Book falls into.



Axsome Therapeutics Price-to-Tangible-Book Calculation

Axsome Therapeutics's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Sep. 2024 )
=85.82/0.602
=142.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Axsome Therapeutics Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Axsome Therapeutics's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Axsome Therapeutics Business Description

Traded in Other Exchanges
Address
One World Trade Center, 22nd Floor, New York, NY, USA, 10007
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

Axsome Therapeutics Headlines

No Headlines